Kennedy Capital Management, Inc. Assertio Holdings, Inc. Transaction History

Kennedy Capital Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.02 - $2.57 $508,211 - $1.28 Million	-498,247 Reduced 62.74%	295,840 $316,000
Q3 2023 Nov 14, 2023	BUY	$2.52 - $5.69 $156,088 - $352,438	61,940 Added 8.46%	794,087 $2.03 Million
Q2 2023 Aug 14, 2023	BUY	$5.0 - $7.66 $2.25 Million - $3.45 Million	450,752 Added 160.18%	732,147 $3.97 Million
Q4 2022 Feb 14, 2023	BUY	$2.11 - $4.3 $373,240 - $760,631	176,891 Added 169.27%	281,395 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$2.13 - $4.0 $222,593 - $418,016	104,504 New	104,504 $237,000

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $41.9M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.